Font Size: a A A

Effect Of FoxO1-shRNA Plasmid On Expression Of AQP9 In Human Normal Hepatic Cell Line

Posted on:2012-04-12Degree:MasterType:Thesis
Country:ChinaCandidate:X XiaoFull Text:PDF
GTID:2154330335987079Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
Objective To select the most potent plasmid vector using transient transfection of distinct shRNA plasmids specific for FoxO1 to human normal hepatic cell line L-02, and to evaluate the effect of FoxO1 gene silence on expression of AQP9 in L-02.Methods Four shRNA plasmids specific for FoxO1 were transfected to L-02 by liposome, and the transfection efficiencies were evaluated via fluorescence microscope. RT-PCR and western-blot were performed to select the most potent FoxO1-shRNA, which was next transfected to L-02 afresh to determine its effect on expression of AQP9 at transcriptional and translational levels. The time transcription for AQP9 regulated by FoxO1 was gained by real-time PCR in different time after transfaction.Results FoxO1-shRNA2 was the most potent vector among the four FoxO1-specific plasmids (FoxO1-shRNA1-4) which led to different gene silence effect. In contrast to control group, the mRNA and protein expression of FoxO1 were inhibited significantly by FoxO1-shRNA2 (P<0.05), and subsequently, the expression of AQP9 were inhibited at both transcriptional and translational levels (P<0.05). The exspression of AQP9 mRNA observed by real-time PCR decreased in time-depended, and the peaked at 60h after transfaction (P<0.05).Conclusions The expression of AQP9 in hepatic cells is decreased by FoxO1-specific plasmids, The expression of AQP9 in hepatic cells is decreased by FoxO1-specific plasmids. The determination of AQP9 transcription time by real-time PCRh provide experiment support in researching the dynamic variation of the combination between FoxO1 and IRE within AQP9 promoter by Chromatin Immunoprecipitation.
Keywords/Search Tags:AQP9, FoxO1, transfaction, human normal hepatic cell line
PDF Full Text Request
Related items